Inventor · Boston, MA, US

Atsushi Endo

31Patents
11h-index
59Co-inventors
74Inventor score

Filing activity: Oct 3, 2008 → Apr 10, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US8093410B2 Intermediates and methods for the synthesis of halichondrin B analogs Emerging Cross-Sectional Technologies 58 Active
US8350067B2 Compounds useful in the synthesis of halichondrin B analogs Emerging Cross-Sectional Technologies 56 Active
US8203010B2 Compounds useful in the synthesis of halichondrin B analogs Emerging Cross-Sectional Technologies 52 Active
US8927597B2 Compounds useful in the synthesis of halichondrin B analogs Emerging Cross-Sectional Technologies 43 Active
US8987479B2 Intermediates and methods for the synthesis of halichondrin B analogs Emerging Cross-Sectional Technologies 43 Active
US9382262B2 Compounds useful in the synthesis of halichondrin B analogs Emerging Cross-Sectional Technologies 36 Active
US9428495B2 Selectively substituted quinoline compounds Chemistry; Metallurgy 33 Active
US9126999B2 Tetrahydropyrazolopyrimidine compounds Emerging Cross-Sectional Technologies 30 Active
US9604993B2 Intermediates and methods for the synthesis of halichondrin B analogs Emerging Cross-Sectional Technologies 17 Active
US9802953B2 Intermediates and methods for the synthesis of halichondrin B analogs Emerging Cross-Sectional Technologies 16 Active
US9856276B2 Compounds useful in the synthesis of halichondrin B analogs Emerging Cross-Sectional Technologies 16 Active
US10214539B2 Intermediates and methods for the synthesis of halichondrin B analogs Emerging Cross-Sectional Technologies 11 Active
US10494388B2 Compounds useful in the synthesis of halichondrin B analogs Emerging Cross-Sectional Technologies 8 Active
US9446046B2 Tetrahydropyrazolopyrimidine compounds Emerging Cross-Sectional Technologies 6 Active
US9850242B2 Tetrahydropyrazolopyrimidine compounds Emerging Cross-Sectional Technologies 2 Active
US10717743B2 Intermediates and methods for the synthesis of halichondrin B analogs Emerging Cross-Sectional Technologies 2 Active
US10640500B2 Tetrahydropyrazolopyrimidine compounds Emerging Cross-Sectional Technologies 1 Active
US9663486B2 Selectively substituted quinoline compounds Chemistry; Metallurgy 1 Active
US10246480B2 Compounds for the treatment of cancer Chemistry; Metallurgy 1 Active
US10457698B2 Chiral reagents for preparation of substituted phosphorodiamidate morpholino oligomers Chemistry; Metallurgy 1 Active
US10745387B2 Crystalline form of (2S,3S,6S,7R,10R,E)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-((R,2E,4E)-6-(piridin-2-yl)hepta-2,4-dien-2-yl)oxacyclododec-4-en-6-yl-4-methylpiperazine-1-carboxylate and methods of use thereof Chemistry; Metallurgy 0 Active
US10087174B2 Selectively substituted quinoline compounds Chemistry; Metallurgy 0 Active
US10836784B2 Substituted phosphorodiamidate morpholino oligomers Chemistry; Metallurgy 0 Active
US11130758B2 Tetrahydropyrazolopyrimidine compounds Emerging Cross-Sectional Technologies 0 Active
US10981929B2 Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof General 0 Revoked

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.